249 filings
8-K
MTEM
Molecular Templates Inc
3 Jun 24
Molecular Templates, Inc. Provides Interim Update
8:13am
8-K
MTEM
Molecular Templates Inc
15 May 24
Molecular Templates, Inc. Reports First Quarter 2024 Financial Results and Corporate Update
5:18pm
8-K
MTEM
Molecular Templates Inc
12 Apr 24
Cost Associated with Exit or Disposal Activities
4:22pm
8-K
MTEM
Molecular Templates Inc
29 Mar 24
Molecular Templates, Inc. Reports Fourth Quarter 2023 Financial Results and Business Update
8:45am
8-K
MTEM
Molecular Templates Inc
28 Mar 24
Molecular Templates Announces $9.5 Million Private Placement Offering and Agreement to Amend Second Tranche of July 2023 Purchase Agreement
8:22am
8-K
4n0r 175cqnm19t8
15 Mar 24
Termination of a Material Definitive Agreement
4:08pm
8-K
0q1v1t0
17 Jan 24
Departure of Directors or Certain Officers
4:04pm
8-K
uxpgxky3o73b 5e
13 Nov 23
Molecular Templates, Inc. Reports Third Quarter 2023 Financial Results and Business Update
4:13pm
8-K
7ibbbaz 0yh
27 Oct 23
Submission of Matters to a Vote of Security Holders
4:12pm
8-K
6kkrz2
28 Sep 23
Molecular Templates Announces the Appointment of Dr. Maurizio Voi to the Role of Chief Medical Officer
5:01pm
8-K
19lwavcbscslrfjt f6
31 Aug 23
Other Events
4:11pm
8-K
bvgeb c2w2qb
11 Aug 23
Molecular Templates Announces 1-for-15 Reverse Stock Split
4:12pm
8-K
nllgisnc
10 Aug 23
Molecular Templates, Inc. Reports Second Quarter 2023 Financial Results and Business Update
8:09am
8-K
o2w vt4pv9d2
2 Aug 23
Molecular Templates Announces Executive Leadership Changes
4:16pm
8-K
gxhvbcgg 9tg0w
13 Jul 23
Molecular Templates Announces Up to $40 Million Private Placement Offering
12:48pm
8-K
j2w8wsu9nhaj3mzqoz
20 Jun 23
Molecular Templates Announces Debt Payoff and Restructuring
7:00am
8-K
ra79xcgfqe tdmgn
16 Jun 23
Molecular Templates Announces Debt Payoff and Restructuring
8:56pm
8-K
5i3a9k 967nga1au
1 Jun 23
Other Events
7:59am
8-K
kigj3r4uvdflqmas154
26 May 23
Molecular Templates to Present on Phase I Dose Escalation Study of MT-6402 at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
5:16pm
8-K
8rxs8s2l6
15 May 23
Molecular Templates, Inc. Reports First Quarter 2023 Financial Results and Business Update
4:49pm